• Programme 2024
• Programme 2023
• Programme 2022
• Programme 2020
• CME 2020
• Programme 2019
• Programme 2018
• CME 2018
• Programme 2017
• CME 2017
• Programme 2016

Scientific Programme 2022

Wednesday 19th January 2022
Moderator: Hans Eiskjaer + one young investigator
	(20 min talk and 10 min discussion)
16.00–16.30	The Future of Machine Perfusion in DCD Organ Transplantation	Andres Wallinder. TBC
16.30–17.00	Development of DCD transplantation in Europe: Hearte	Michiel Erasmus Groningen
17.00–17.30	Is Two Really Better Than One? Multi-Organ Cardiothoracic transplantation	Clive Lewis Cambridge
17.30–18.00	Coffee Break	Â
18.00–19.20	Fascinating Failures and Surprising Successes-Case - 4 Case presentation sections (10 mins. Talk - 10 mins. Questions)
	18.00–18.20 Post-partum dyspnea: Complexity of Acute Listing and Urgent Transplant in patients evaluated for Lung Transplant following cardiac arrest on ECMO	Göran Rådegran Lund
	18.20–18.40 The First DCD Heart in the Netherlands	Nils van der Kaay, Groningen
	18.40–19.00 Heart-Kidney Transplant from Durable LVAD and Centrimag RVAD Support	Clive Lewis, Cambridge
	19.00–19.20 Lung Transplantation following COVID-19 ARDS	Anders Andreasson, Vienna
Thursday 20th January 2022 Focus on Long Term Problems in Cardiothoracic Transplantation
Moderator: Clive Lewis + young investigator.
16.00–16.20	Heart Transplantation: The Road Ahead	Hans Eiskjaer,  Aarhus
16.20–16.40	Renal dysfunction post LVAD: measured GFR	Sven-Erik Bartfay,  Gothenburg
16.40–17.00	Chronic Lung Allograft Dysfunction (CLAD)	Robin Vos, Leuven
17.00–17.20	CLAD: The ScanCLAD Study	Göran Dellgren, Gothenburg
17.20–17.40	Business Meeting
17.40–18.00	Coffee break
18.00–18.20	Cardiac Allograft Vasculopathy	Tor Clemmensen, Aarhus
18.20–18.40	Advances in Immunosuppression	Erik Verschuuren, Groningen
18.40–19.30	LVAD Therapy will be the New Standrard for most Patients with End Stage Heart Failure	Stephan Schueler Newcastle
Friday 21st January 2022
Moderator: Göran Dellgren + one young investigator
	(10-20 min talks and 10 min discussion)
16.00–16.20	Cardiothoracic Transplantation in the setting of COVID-19	Margaret Hannan, Dublin
16.20–16.40	Torque Tenovirus monitoring in Heart Transplantation	Hans Eiskjaer, Aarhus
16.40–17.00	High Risk Donors and Hepatitis C including feedback from ESHLT symposium	Margaret Hannan Dublin
17.00–17.30	WERNER ZUBER MEMORIAL LECTURE
	17.00–17.30 Ötzi, The Iceman	Prof Frank Rüehli, Zurich
17.30–18.00	Coffee break
18.00–19.30	Young Investigators Abstract Presentations (10 mins. Talk - 5 mins. Questions)
	18.00–18.15 Normothermic regional perfusion of circulatory dead donor hearts: Optimal reperfusion time?	Niels Moeslund Aarhus
	18.15–18.30 Impact of COVID-19 lockdown on lung transplant recipients: decline in overall respiratory virus infections is associated with stabilization of lung function	Auke de Zwart Groningen
	18.30–18.45 Clinical Experience with The Cold Storage SherpaPakTM System for Donor Heart Transportation	Hassiba Smail Harefield
	18.45–19.00 Waiting list dynamics and lung transplant outcomes after introduction of the lung allocation score in the Netherlands	Thijs Hoffman Nieuwegein
	19.00–19.15 Clinical consequences of Immunosuppression after Heart Transplantation with reference to osteoporosis and renal function	Eveline Löfdahl Lund
	19.15–19.30 ESOT Transplant Fellowship: Clinical and Academic opportunities	Anders Andreasson Vienna

Hep-C Donor Working Group

We are developing a morning workshop on Hepatitis C donors in cardiothoracic transplantation. If you are interested in attending the workshop please send a message to our administrative secretary Anne Lawless (annelawless@mater.ie).

List of potential participants.